Envestnet Asset Management
IMGN

Envestnet Asset Management’s Immunogen Inc IMGN Stock Holding History

Envestnet Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,695
Closed -$1.27M – 4326
2023
Q4 		$1.27M Sell
42,695
-21,777
-34% -$434K ﹤0.01% 2754
2023
Q3 		$1.02M Buy
64,472
+35,856
+125% +$596K ﹤0.01% 2800
2023
Q2 		$540K Buy
+28,616
New +$338K ﹤0.01% 3161
2022
Q4 		– Sell
-42,726
Closed -$204K – 4106
2022
Q3 		$204K Sell
42,726
-13,183
-24% -$69.5K ﹤0.01% 3576
2022
Q2 		$252K Sell
55,909
-3,160
-5% -$13.7K ﹤0.01% 3459
2022
Q1 		$281K Sell
59,069
-5,604
-9% -$31K ﹤0.01% 3494
2021
Q4 		$480K Buy
64,673
+326
+0.5% +$2.03K ﹤0.01% 3098
2021
Q3 		$365K Buy
64,347
+1,975
+3% +$11.4K ﹤0.01% 3172
2021
Q2 		$411K Buy
62,372
+2,064
+3% +$14.4K ﹤0.01% 3100
2021
Q1 		$488K Buy
60,308
+4,583
+8% +$37.4K ﹤0.01% 2860
2020
Q4 		$359K Sell
55,725
-2,566
-4% -$15K ﹤0.01% 2830
2020
Q3 		$210K Buy
58,291
+1,212
+2% +$4.89K ﹤0.01% 2896
2020
Q2 		$263K Sell
57,079
-4,962
-8% -$21.1K ﹤0.01% 2746
2020
Q1 		$212K Sell
62,041
-5,519
-8% -$24.1K ﹤0.01% 2702
2019
Q4 		$345K Sell
67,560
-1,794
-3% -$6.09K ﹤0.01% 2672
2019
Q3 		$168K Sell
69,354
-1,595
-2% -$4.24K ﹤0.01% 2903
2019
Q2 		$154K Buy
70,949
+7,790
+12% +$18.4K ﹤0.01% 2919
2019
Q1 		$171K Buy
63,159
+12,671
+25% +$54.9K ﹤0.01% 2853
2018
Q4 		$242K Buy
+50,488
New +$306K ﹤0.01% 2555
2018
Q3 		– Sell
-24,728
Closed -$240K – 2754
2018
Q2 		$240K Sell
24,728
-526
-2% -$5.54K ﹤0.01% 1592
2018
Q1 		$265K Sell
25,254
-7,031
-22% -$69.4K ﹤0.01% 1466
2017
Q4 		$207K Buy
32,285
+6,459
+25% +$39.8K ﹤0.01% 1831
2017
Q3 		$196K Sell
25,826
-1,076
-4% -$7.15K ﹤0.01% 1845
2017
Q2 		$192K Sell
26,902
-859
-3% -$3.93K ﹤0.01% 1897
2017
Q1 		$107K Buy
27,761
+743
+3% +$2.17K ﹤0.01% 2163
2016
Q4 		$54K Sell
27,018
-978
-3% -$1.96K ﹤0.01% 2416
2016
Q3 		$75K Sell
27,996
-18,047
-39% -$52.5K ﹤0.01% 2448
2016
Q2 		$142K Sell
46,043
-3,842
-8% -$24.1K ﹤0.01% 2279
2016
Q1 		$425K Sell
49,885
-6,098
-11% -$51.6K ﹤0.01% 1715
2015
Q4 		$760K Sell
55,983
-3,056
-5% -$37.6K ﹤0.01% 1413
2015
Q3 		$567K Buy
59,039
+7,349
+14% +$107K ﹤0.01% 1536
2015
Q2 		$743K Buy
51,690
+2,525
+5% +$27.7K ﹤0.01% 1539
2015
Q1 		$440K Buy
49,165
+48,291
+5,525% +$350K ﹤0.01% 1614
2014
Q4 		$5K Sell
874
-137
-14% -$1.25K ﹤0.01% 2162
2014
Q3 		$11K Sell
1,011
-11
-1% -$124 ﹤0.01% 2103
2014
Q2 		$12K Sell
1,022
-159
-13% -$2K ﹤0.01% 1965
2014
Q1 		$18K Buy
1,181
+43
+4% +$678 ﹤0.01% 1687
2013
Q4 		$17K Sell
1,138
-14
-1% -$215 ﹤0.01% 1560
2013
Q3 		$20K Sell
1,152
-445
-28% -$7.82K ﹤0.01% 1485
2013
Q2 		$26K Buy
+1,597
New +$25.9K ﹤0.01% 1359

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Envestnet Asset Management's IMGN Position: Q1 2024 in Review

Envestnet Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 42,695 shares — an estimated $1.27M sold.

Envestnet Asset Management first reported a position in IMGN in Q2 2013 and held it in 40 quarters. The position peaked at $1.27M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Envestnet Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 42,695 Immunogen Inc shares in Q1 2024, an estimated $1.27M.
  • Envestnet Asset Management first reported a position in Immunogen Inc in Q2 2013 and held it in 40 quarters.
  • Envestnet Asset Management's Immunogen Inc position peaked at $1.27M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Envestnet Asset Management's 13F filing for Q1 2024, filed 13 May 2024.